This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Stop the Linsanity: Buy MSG Stock Now

There's no good reason for MSG to underperform the NASDAQ Composite (^IXIC). If you read the headlines during the height of Linsanity, Jeremy Lin received practically all of the credit for MSG's rise. Now, as he signs elsewhere, he receives just as much credit for the stock's demise.

The sad part of it all is that he deserves the credit. That's the type of stock market -- and world -- we roll in. It's a fickle, reactionary, headline-reading, brain-sucking atmosphere that, for better or worse, produces my livelihood. I shouldn't complain because being able to see what's happening and react to it appropriately provides me with an edge, albeit a qualitative one.

If one man does not make a sports franchise, one man certainly does not make a stock. And it's not like Jeremy Lin is even anything close to a proven commodity. The Knicks might end up the smartest guys in the room for not signing a player who could very easily amount to a one-hit wonder. But, that's not even the point. In fact, it distracts from it.

MSG Is Bigger Than One Man

The fact that Linsanity even impacted the stock in the first place is almost completely crazy. I say "almost" because with interest comes more eyeballs and ratings, which potentially brings more ad dollars for MSG's television networks, and more merchandise sales. But Knicks tickets were going to sell with or without Lin.

The fact that Linsanity impacted the stock to the downside, as it has in recent days, is nothing but a farce. If it did not present such an excellent buying opportunity for MSG stock, I might be angry about it.

When MSG reports fiscal fourth-quarter earnings sometime in August, Jeremy Lin's name will not even come up. It should have been only a small part of what has never been a serious conversation about this company.

MSG does well for several reasons.

One, it owns valuable sports teams. The Knicks and especially the NHL's New York Rangers both went deep into the playoffs. That's short-term, somewhat unpredictable stuff, but it counts.
2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
BCE $42.50 0.00%
MSG $83.49 0.00%
P $15.54 0.00%
RCI $35.53 0.00%
SIRI $3.75 0.54%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.11 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs